LIMK1 overexpression increases the invasiveness of breast and prostate cancer cells in vitro and in vivo, and knocking down of LIMK1 suppresses breast and prostate cancer cell invasion in vitro and in vivo[19]–[22], [32]. This evidence concerns the gene LIMK1 and prostate carcinoma.